What can we learn in drug allergy management from World Health Organization's international classifications?-Reference-Cited by-同舟云学术

What can we learn in drug allergy management from World Health Organization's international classifications?

Author:

Tanno L. K.¹²³^ORCID,Torres M. J.⁴,Castells M.⁵,Demoly P.²³,

Affiliation:

1. Hospital Sírio Libanês; São Paulo Brazil

2. University Hospital of Montpellier; Montpellier France

3. UMR-S 1136, IPLESP, Equipe EPAR; Sorbonne Universités; UPMC Paris 06; Paris France

4. Allergy Unit; IBIMA-Regional University Hospital of Malaga, UMA; Malaga Spain

5. Division of Rheumatology, Immunology and Allergy; Department of Medicine; Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

Funder

AstraZeneca, as an unrestricted AstraZeneca

MEDA Pharma through CHRUM administration

European Regional Development Fund

Thematic Networks and Co-operative Research Centres: ARADyAL

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

Reference25 articles.

3. International drug monitoring: the role of national centres. Report of a WHO meeting;WHO;World Health Organ Tech Rep Ser,1972

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Editorial: Drug allergy;Current Opinion in Allergy & Clinical Immunology;2022-08